Skip to main content
SpringerLink
Log in

Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus—Impact on Lymph Node Yield and Hemodynamic Parameters

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background

Neoadjuvant therapy followed by surgery is the current recommended treatment for locally advanced esophageal carcinoma. Thoracic duct (TD) resection was indicated for radical mediastinal lymphadenectomy. However, TD resection can cause hemodynamic disturbances. The presence of metastasis in TD has not been previously studied.

Methods

Twenty-two patients who underwent minimally invasive esophagectomy with D2 lymphadenectomy after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma were analyzed. Ten patients had their TD resected from thoracic inlet till the esophageal hiatus. Multiple histopathological sections of the TD were examined for evidence of tumor spread. Intraoperative and immediate (48 h) postoperative hemodynamic parameters, lymph node yield, and postoperative morbidity were compared between TD-resected and TD-preserved groups.

Results

The median postoperative day 1 fluid requirement (3310 mL vs. 2875 mL, P = 0.059) and the median postoperative day 2 pulse rate were higher in the TD-resected group (111/min vs. 95/min, P = 0.043). There was no significant difference in the intraoperative fluid infusion, blood loss, urine output, mean blood pressure, pulse rate, postoperative urine output, and mean blood pressure between two groups. Median (range) mediastinal lymph node count was similar in TD-resected and TD-preserved groups [15(11–32) vs. 14(9–31), P = 0.283]. Pathological examination of TD did not reveal tumor cells in any of the patients. There was no significant difference in the postoperative morbidity between two groups except for cervical anastomotic dehiscence (P = 0.007).

Conclusions

Minimally invasive esophagectomy with TD resection causes minor hemodynamic changes in the immediate postoperative period, without adversely affecting the postoperative outcome. In the setting of neoadjuvant chemoradiotherapy, TD resection does not increase lymph node yield.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hanna JM, Erhunmwunsee L, Berry M, D’Amico T, Onaitis M. The prognostic importance of the number of dissected lymph nodes after induction chemoradiotherapy for esophageal cancer. Ann Thorac Surg. 2015;99(1):265–9. https://doi.org/10.1016/j.athoracsur.2014.08.073.

    Article  PubMed  Google Scholar 

  2. Zhu Z, Chen H, Yu W, Fu X, Xiang J, Li H, et al. Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy. Ann Surg Oncol. 2014;21(9):2857–63. https://doi.org/10.1245/s10434-014-3665-y.

  3. Udagawa H, Akiyama H. Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus. 2001;14(2):110–4. https://doi.org/10.1046/j.1442-2050.2001.00166.x.

    Article  CAS  PubMed  Google Scholar 

  4. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48(5):411–20. https://doi.org/10.1159/000226971.

    Article  CAS  PubMed  Google Scholar 

  5. Ajani JA, Barthel JS, Bentrem DJ, D’Amico TA, Das P, Denlinger CS, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Cancer Netw. 2011;9(8):830–87. https://doi.org/10.6004/jnccn.2011.0072.

    Article  Google Scholar 

  6. Koen Talsma A, Shapiro J, Looman CW, van Hagen P, Steyerberg EW, van der Gaast A, et al. Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg. 2014;260:786–92.

    Article  CAS  PubMed  Google Scholar 

  7. Miyata H, Yamasaki M, Makino T, Miyazaki Y, Takahashi T, Kurokawa Y, et al. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. J Surg Oncol. 2015;112(1):60–5. https://doi.org/10.1002/jso.23965.

  8. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379(9829):1887–92. https://doi.org/10.1016/S0140-6736(12)60516-9.

    Article  Google Scholar 

  9. Murakami G, Sato I, Shimada K, Dong C, Kato Y, Imazeki T. Direct lymphatic drainage from the esophagus into the thoracic duct. Surg Radiol Anat. 1994;16(4):399–407. https://doi.org/10.1007/BF01627660.

    Article  CAS  PubMed  Google Scholar 

  10. Saito H, Sato T, Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat. 2007;29(7):531–42. https://doi.org/10.1007/s00276-007-0257-6.

    Article  PubMed  Google Scholar 

  11. Udagawa H, Ueno M, Shinohara H, Haruta S, Lee S, Momose K, et al. Should lymph nodes along the thoracic duct be dissected routinely in radical esophagectomy? Esophagus. 2014;11(3):204–10. https://doi.org/10.1007/s10388-014-0433-9.

  12. Imamura M, Shimada Y, Kanda T, Miyahara T, Hashimoto M, Tobe T, et al. Hemodynamic changes after resection of thoracic duct for en bloc resection of esophageal cancer. Surg Today. 1992;22(3):226–32. https://doi.org/10.1007/BF00308827.

    Article  CAS  PubMed  Google Scholar 

  13. Aiko S, Yoshizumi Y, Matsuyama T, Suguira Y, Maehara T. Influences of thoracic duct blockage on early enteral nutrition for patients who underwent esophageal cancer surgery. Jpn J Thorac Cardiovas Surg. 2003;51(7):263–71. https://doi.org/10.1007/BF02719376.

    Article  Google Scholar 

  14. Guler O, Ugras S, Aydin M, Dilek FH, Dilek ON, Karaayvaz M. The effect of lymphatic blockage on the amount of endotoxin in portal circulation, nitric oxide synthesis, and the liver in dogs with peritonitis. Surg Today. 1999;29(8):735–40. https://doi.org/10.1007/BF02482318.

    Article  CAS  PubMed  Google Scholar 

  15. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84. https://doi.org/10.1056/NEJMoa1112088.

  16. Japan Esophageal Society. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 10th ed. Tokyo, Japan: Kanehara Co; 2007.

    Google Scholar 

  17. Collard JM, Romagnoli R, Goncette L. Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg. 1998;65(3):814–7. https://doi.org/10.1016/S0003-4975(97)01384-2.

    Article  CAS  PubMed  Google Scholar 

  18. Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, XB DJ, et al. International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg. 2015;262(2):286–94. https://doi.org/10.1097/SLA.0000000000001098.

    Article  Google Scholar 

  19. Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer. 2003;98(7):1521–30. https://doi.org/10.1002/cncr.11660.

  20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009. p. 103–15.

    Google Scholar 

  21. Varela E, Reavis KM, Hinojosa MW, Nguyen N. Laparoscopic gastric ischemic conditioning prior to esophagogastrectomy: technique and review. Surg Innov. 2008;15(2):132–5. https://doi.org/10.1177/1553350608317352.

    Article  PubMed  Google Scholar 

  22. Lai FC, Chen L, YR T, Lin M, Li X. Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study. Ann Thorac Surg. 2011;91(6):1770–4. https://doi.org/10.1016/j.athoracsur.2011.02.070.

    Article  PubMed  Google Scholar 

  23. Cagol M, Ruol A, Castoro C, Alfieri A, Michieletto S, Ancona E. Prophylactic thoracic duct mass ligation prevents chylothorax after transthoracic esophagectomy for cancer. World J Surg. 2009;33(8):1684–6. https://doi.org/10.1007/s00268-009-0094-3.

    Article  PubMed  Google Scholar 

  24. Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, et al. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2013;20(9):3038–43. https://doi.org/10.1245/s10434-013-2988-4.

  25. Ikebe M, Morita M, Yamamoto M, Toh Y. Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management. Gen Thorac Cardiovasc Surg. 2016;64(7):386–94. https://doi.org/10.1007/s11748-016-0655-y.

    Article  PubMed  Google Scholar 

  26. Phillips AW, Lagarde SM, Navidi M, Disep B, Griffin SM. Impact of extent of lymphadenectomy on survival, post neoadjuvant chemotherapy and transthoracic esophagectomy. Ann Surg. 2017;265(4):750–6. https://doi.org/10.1097/SLA.0000000000001737.

    Article  PubMed  Google Scholar 

  27. Matsuda S, Takeuchi H, Kawakubo H, Shimada A, Fukuda K, Nakamura R, et al. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct. Medicine (Baltimore). 2016;95(24):e3839. https://doi.org/10.1097/MD.0000000000003839.

  28. Robb WB, Dahan L, Mornex F, Maillard E, Thomas PA, Meunier B, et al. Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trial. Ann Surg. 2015;261(5):902–8. https://doi.org/10.1097/SLA.0000000000000991.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Gastroenterology, JIPMER, Room no 551, Fourth floor, Superspeciality block, Puducherry, 605006, India

    Santosh Anand, Raja Kalayarasan, Sandip Chandrasekar, Senthil Gnanasekaran & Biju Pottakkat

Authors
  1. Santosh Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raja Kalayarasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandip Chandrasekar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Senthil Gnanasekaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Biju Pottakkat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raja Kalayarasan.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anand, S., Kalayarasan, R., Chandrasekar, S. et al. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus—Impact on Lymph Node Yield and Hemodynamic Parameters. J Gastrointest Canc 50, 230–235 (2019). https://doi.org/10.1007/s12029-018-0051-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-018-0051-1

Keywords

Search

Navigation